DUSTIN PINE: Open Payments
NPI 1619381597 · MC CONNELLSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 28 payments from 13 companies in 2025. Trend: 2023 $430 · 2024 $744 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $126 |
| BridgeBio Pharma, Inc. | 3 | $120 |
| Alnylam Pharmaceuticals Inc. | 3 | $89 |
| Amgen Inc. | 3 | $56 |
| PFIZER INC. | 3 | $56 |
| Novo Nordisk Inc | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
Products named: LEQVIO, Attruby, REPATHA, ONPATTRO, Wegovy, AMVUTTRA, VYNDAQEL, JARDIANCE.
Industry payments across PA — which companies pay providers there.
